Menu Menu

ALZN    Alzamend Neuro Inc    1677077    
Income Statement
Net Income -1,415,214

Balance Sheet
Current Assets 4,766,742
Assets 5,007,718
Current Liabilities 3,826,457
Liabilities 1,254,750
Equity 3,752,968
Shares Out 3,890,000

Cash Flow Statement
Operating Cash Flow -4,455,843
Investing Cash Flow -90,000

Market Analysis
Market Cap 6,729,807
Price 1.16
BVPS 0.96
PB 1.18
EPS -10.69
PS 55.03
FCF -4,545,843
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
0.90
Apr May Jun
Jul Aug Sep
7/25
Oct Nov Dec

Find a discrepancy? The most accurate way to find company fundamental data is to view ALZN documents filed with the SEC.


ALZN Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: